Positron emission tomography (PET) with 89Zr-labeled trastuzumab (89Zr-trastuzumab): Monitoring HER2 expression in HER2-positive gastric cancer in vivo.
Yelena Y. Janjigian
Disclosure not yet available
Nerissa T. Villegas
Disclosure not yet available
Jason P. Holland
Disclosure not yet available
Manish A. Shah
Disclosure not yet available
Vadim Divilov
Disclosure not yet available
David P. Kelsen
Disclosure not yet available
Jason S. Lewis
Disclosure not yet available